Pseudomonas Aeruginosa Infection Treatment Market to Grow with a CAGR of 6.14% through 2028
Increasing incidence of infections associated with
it such as pneumonia, cystic fibrosis, and urinary tract infections are
expected to drive the Global Pseudomonas Aeruginosa Infection Treatment Market
growth in the forecast period, 2024-2028.
According to
TechSci Research report, “Pseudomonas Aeruginosa Infection Treatment Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Pseudomonas
Aeruginosa Infection Treatment Market stood at USD 1.43 Billion in 2022 and is
anticipated to grow with a CAGR of 6.14% through 2028. The major factors such
as the increasing incidence of infections associated with it such as pneumonia,
cystic fibrosis, and urinary tract infections, the increasing development of
products, increasing antibacterial resistance, and growing R&D activities
are driving the growth of the Pseudomonas aeruginosa infection market. The
prevalence of hospital-acquired infections has increased in recent years.
According to an article published in the National Library of Medicine in August
2022, the estimated worldwide incidence of community-acquired pneumonia varies
between 1.5 and 14 cases per 1000 person-years, and this is affected by
geography, season, and population characteristics. In the United States, the
annual incidence is 24.8 cases per 10,000 adults, with higher rates as age
increases. As a result of the increased burden of P. aeruginosa infection, the
demand for its treatment is predicted to rise over the projection period,
thereby boosting the growth of the studied market.
Furthermore,
growing research and development activities on pseudomonas aeruginosa infection
are expected to support market expansion over the forecast period. For
instance, according to ClinicalTrials.gov updated in October 2022, a study
titled "A Phase 1b/2 Trial of the Safety and Microbiological Activity of
Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas
Aeruginosa" is under phase II trials and expected to be completed by 2024.
Thus, such a study is expected to bring an advanced product for treating
pseudomonas aeruginosa infection, thereby boosting the market's growth.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Pseudomonas Aeruginosa Infection Treatment Market”
The Global Pseudomonas
Aeruginosa Infection Treatment Market is segmented into Medication Type, Drug Type, Route Of Administration, Distribution
Channel, and company.
Based on the
Product, the Transdermal patches segment is anticipated to witness substantial
market growth throughout the forecast period. The Global Pseudomonas Aeruginosa
Infection Treatment Market is poised for significant growth propelled by the
increasing prominence of transdermal patches. These innovative patches,
combining pharmaceuticals with specialized delivery systems, offer a convenient
and non-invasive approach to drug administration. The rising demand for
patient-friendly alternatives to traditional dosage forms, such as oral
medications or injections, positions transdermal patches as a key driver in the
market. Transdermal patches provide controlled and sustained drug release,
improving treatment adherence and minimizing fluctuations in drug levels. They
offer advantages in terms of ease of use, reduced side effects, and enhanced
patient comfort. Additionally, the patches cater to the growing preference for
self-administration, empowering patients to manage their healthcare more
independently.
Based on the
Distribution Channel segment, the Hospital Pharmacies segment has been the
dominant force in the market. Hospital Pharmacies are poised to play a pivotal
role in propelling the growth of the Global Pseudomonas Aeruginosa Infection
Treatment Market. As primary points of dispensing medications within healthcare
institutions, hospital pharmacies are critical stakeholders in the effective
management and treatment of infectious diseases, including those caused by
Pseudomonas Aeruginosa. The demand for specialized and advanced infection
treatments is significantly high within hospital settings, where patients with
severe infections often receive medical care. Hospital pharmacies are crucial
in ensuring the availability and timely dispensing of cutting-edge Pseudomonas
Aeruginosa infection treatments, contributing directly to patient care and
recovery.
Major companies
operating in Global Pseudomonas Aeruginosa Infection Treatment Market are:
- Allergan, Inc.
- Teva Pharmaceutical
Industries Ltd.
- Pfizer Inc.
- AstraZeneca PLC.
- Merck & Co.
Inc.
- Bristol-Myers
Squibb Co.
- Janssen
Pharmaceuticals Inc.
- Lupin
Pharmaceuticals, Inc.
- Baxter
International Inc.
- Sanofi SA.
Download Free Sample Report
Customers can
also request 10% free customization on this report
“The prevalence
of hospital-acquired infections has increased in recent years. Growing research and development activities on
pseudomonas aeruginosa infection are expected to support market expansion over
the forecast period. Various organic
and inorganic strategies by the market players are likely to support the growth
of the market. The growing
prevalence of pseudomonas aeruginosa infection and rising drug development and
discovery activities, are expected to propel the growth of the market over the
forecast period. However, drug resistance ability of pseudomonas aeruginosa may
restraint the market growth over the forecast period.” said Mr. Karan Chechi,
Research Director with TechSci Research, a research-based management consulting
firm.
“Pseudomonas
Aeruginosa Infection Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2018-2028 Segmented By Medication Type (Monotherapy,
Combination Therapy), By Drug Type (Aminoglycoside, Cephalosporin, Carbapenem,
Monobactam, Others), By Route Of Administration (Nasal, Oral, Intravenous), By
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies), By Region, By Competition”, has evaluated
the future growth potential of Global Pseudomonas Aeruginosa Infection
Treatment Market and provides statistics
& information on market size, structure and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Global Pseudomonas Aeruginosa Infection Treatment Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com